Back to Journals » Drug Design, Development and Therapy » Volume 9

A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects

Total article views   Abstract views HTML views PDF downloads Totals
14,316 Dovepress* 8,134 3,324+ 1,896 11,458
PubMed Central* 0 2,858 725 2,858
Totals 8,134 6,182 2,621 14,316
*Since 4 February 2015
+Since July 2016

View citations on PubMed Central and Google Scholar